| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Cardiovascular Division (T.J.H., E.R., R.C., M.G., J.C.K.), Kings College London, St. Thomas Campus; Department of Anaesthesia (G.K.), Kings College Hospital, Denmark Hill Campus, London; and The Randall Centre (E.R., M.G.), New Hunts House, Kings College London, UK. Present address for T.J.H.: Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor. Present address for R.C.: Division of Cardiology, Hospital for Sick Children, Toronto, Ontario, Canada.
Correspondence to Jonathan C. Kentish, MA, PhD, Cardiovascular Division, Kings College London, Rayne Institute, St. Thomas Hospital, London, SE1 7EH, United Kingdom. E-mail jon.kentish{at}kcl.ac.uk
Myosin binding protein-C (MyBP-C) is a poorly understood component of the thick filament in striated muscle sarcomeres. Its C terminus binds tightly to myosin, whereas the N terminus contains binding sites for myosin S2 and possibly for the thin filament. To study the role of the N-terminal domains of cardiac MyBP-C (cMyBP-C), we added human N-terminal peptide fragments to human and rodent skinned ventricular myocytes. At concentrations >10 µmol/L, the N-terminal C0C2 peptide activated force production in the absence of calcium (pCa 9). Force at the optimal concentration (80 µmol/L) of C0C2 was
60% of that in maximal Ca2+ (pCa 4.5), but the rate constant of tension redevelopment (ktr) matched or exceeded (by up to 80%) that produced by Ca2+ alone. Experiments using different N-terminal peptides suggested that this activating effect of C0C2 resulted from binding by the pro/ala-rich C0-C1 linker region, rather than the terminal C0 domain. At a lower concentration (1 µmol/L), exogenous C0C2 strongly sensitized cardiac myofibrils to Ca2+ at a sarcomere length (SL) of 1.9 µm but had no significant effect at SL 2.3 µm. This differential effect caused the normal SL dependence of myofibrillar Ca2+ sensitivity to be reduced by 80% (mouse myocytes) or abolished (human myocytes) in 1 µmol/L C0C2. These results suggest that cMyBP-C provides a regulatory pathway by which the thick filament can influence the activation of the thin filament, separately from its regulation by Ca2+. Furthermore, the N-terminal region of cMyBP-C can influence the SL-tension (FrankStarling) relationship in cardiac muscle.
Key Words: myosin binding protein C cardiac myocytes Ca2+ sensitization sarcomere length FrankStarling mechanism
Related Article:
Circ. Res. 2006 98: 1234-1236.
This article has been cited by other articles:
![]() |
Y. Lecarpentier, N. Vignier, P. Oliviero, A. Guellich, L. Carrier, and C. Coirault Cardiac Myosin-Binding Protein C Modulates the Tuning of the Molecular Motor in the Heart Biophys. J., July 15, 2008; 95(2): 720 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nagayama, E. Takimoto, S. Sadayappan, J. O. Mudd, J.G. Seidman, J. Robbins, and D. A. Kass Control of In Vivo Contraction/Relaxation Kinetics by Myosin Binding Protein C: Protein Kinase A Phosphorylation Dependent and Independent Regulation Circulation, November 20, 2007; 116(21): 2399 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pohlmann, I. Kroger, N. Vignier, S. Schlossarek, E. Kramer, C. Coirault, K. R. Sultan, A. El-Armouche, S. Winegrad, T. Eschenhagen, et al. Cardiac Myosin-Binding Protein C Is Required for Complete Relaxation in Intact Myocytes Circ. Res., October 26, 2007; 101(9): 928 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kulikovskaya, G. B. McClellan, R. Levine, and S. Winegrad Multiple Forms of Cardiac Myosin-binding Protein C Exist and Can Regulate Thick Filament Stability J. Gen. Physiol., April 30, 2007; 129(5): 419 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Razumova, J. F. Shaffer, A.-Y. Tu, G. V. Flint, M. Regnier, and S. P. Harris Effects of the N-terminal Domains of Myosin Binding Protein-C in an in Vitro Motility Assay: EVIDENCE FOR LONG-LIVED CROSS-BRIDGES J. Biol. Chem., November 24, 2006; 281(47): 35846 - 35854. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sadayappan, H. Osinska, R. Klevitsky, J. N. Lorenz, M. Sargent, J. D. Molkentin, C. E. Seidman, J. G. Seidman, and J. Robbins Cardiac myosin binding protein c phosphorylation is cardioprotective PNAS, November 7, 2006; 103(45): 16918 - 16923. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. de Tombe Myosin Binding Protein C in the Heart Circ. Res., May 26, 2006; 98(10): 1234 - 1236. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |